Question
(
- (a)Classify the drugs used in the pharmacotherapy of Peptic ulcer. Discuss the pharmacological management of Helicobacter pylori infection. ( 3 mark(s)
- (b)Briefly describe Methotrexate. 2 mark(s)
Answer
a) Classification for peptic ulcer, and H. pylori management
| Group | Examples |
|---|---|
| Proton pump inhibitors | Omeprazole |
| H2 receptor antagonists | Ranitidine |
| Antacids | Aluminium hydroxide |
| Mucosal protective agents | Sucralfate, Misoprostol |
Management of H. pylori infection: standard triple therapy — a PPI plus two antibiotics (typically Clarithromycin and Amoxicillin, or Metronidazole in penicillin-allergic patients) for 10-14 days; bismuth-based quadruple therapy (Bismuth, Metronidazole, Tetracycline, PPI) is used where clarithromycin resistance is prevalent or triple therapy has failed.
b) Methotrexate A folate-antagonist antimetabolite. MOA: competitively inhibits dihydrofolate reductase, blocking tetrahydrofolate regeneration and halting purine/thymidine synthesis. Uses: acute lymphoblastic leukemia, choriocarcinoma; low-dose — rheumatoid arthritis, psoriasis. Adverse effects: bone marrow suppression, hepatotoxicity, mucositis, teratogenicity.

